Strategy-confirming Study of BMS-955176 to Treat HIV-1 Infected Treatment-experienced Adults

NCT02386098 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

86

Enrollment

INDUSTRY

Sponsor class

Stopped GI Intolerability

Conditions

HIV Infections

Interventions

DRUG: BMS-955176
DRUG: Atazanavir (ATV)
DRUG: Ritonavir (RTV)
DRUG: Dolutegravir (DTG)
DRUG: Tenofovir (TDF)

Sponsor

ViiV Healthcare

Collaborators

[object Object]